Follistatin Suppresses the Production of Experimental Multiple-Organ Metastasis by Small Cell Lung Cancer Cells in Natural Killer Cell–Depleted SCID Mice

Hirokazu Ogino(Tokushima University), Saburo Sone(Io Therapeutics (United States)), Hisanori Uehara(Tokushima University Hospital), Kunihiro Tsuchida(Fujita Health University), Seiji Yano(Kanazawa University Hospital), Hiromu Sugino(Tokushima University), Soji Kakiuchi(Tokushima Prefectural Central Hospital), Kenji Ikuta(Nagoya City University), Masaki Hanibuchi(Tokushima University), Hiroaki Muguruma(Tokushima University)
Clinical Cancer Research
February 1, 2008
10.1158/1078-0432.ccr-07-1221
Cited by 83

Related Papers

Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
|Cancer Research|2008|642
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells
|Nature Communications|2019|360
Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs
|Oncogene|2003|324
Identification and characterization of PDGFRα+ mesenchymal progenitors in human skeletal muscle
|Cell Death and Disease|2014|299
Direct linkage of three tachykinin receptors to stimulation of both phosphatidylinositol hydrolysis and cyclic AMP cascades in transfected Chinese hamster ovary cells.
|Journal of Biological Chemistry|1992|262